| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Jian Li | Q60621562 |
| P2093 | author name string | Roger L Nation | |
| Luciano Zubaran Goldani | |||
| Alexandre Prehn Zavascki | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1206-1215 | |
| P577 | publication date | 2007-09-17 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review | |
| P478 | volume | 60 |
| Q40524324 | A breakthrough on Amanita phalloides poisoning: an effective antidotal effect by polymyxin B. |
| Q40205283 | A broad-spectrum bactericidal lipopeptide with anti-biofilm properties |
| Q38501685 | A review on colistin nephrotoxicity |
| Q38110688 | AApeptides as a new class of antimicrobial agents. |
| Q28475562 | Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis |
| Q39078108 | Adverse drug reactions among patients admitted with infectious diseases at a Brazilian hospital |
| Q38755683 | Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model. |
| Q41964844 | Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa |
| Q52597953 | Alterations of metabolic and lipid profiles in polymyxin-resistant Pseudomonas aeruginosa. |
| Q36171742 | An automated image-based method for rapid analysis of Chlamydia infection as a tool for screening antichlamydial agents |
| Q35120382 | An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria |
| Q37014270 | Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii |
| Q38348964 | Antibacterial mechanisms of polymyxin and bacterial resistance. |
| Q36479306 | Antibacterial properties of 3-(phenylsulfonyl)-2-pyrazinecarbonitrile |
| Q90149455 | Antibiotic resistance pattern of Acinetobacter baumannii from burns patients: increase in prevalence of bla OXA-24-like and bla OXA-58-like genes |
| Q38809110 | Antimicrobial AApeptides. |
| Q37165591 | Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria |
| Q39101863 | Antimicrobial Peptides from Fruits and Their Potential Use as Biotechnological Tools-A Review and Outlook. |
| Q37532896 | Antimicrobial Peptides: An Emerging Category of Therapeutic Agents |
| Q90438044 | Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations |
| Q38202581 | Antimicrobial agents, drug adverse reactions and interactions, and cancer |
| Q92015465 | Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model |
| Q46257693 | Antimicrobial octapeptin C4 analogues active against Cryptococcus species. |
| Q42276631 | Antimicrobial peptides for gram-negative sepsis: a case for the polymyxins |
| Q38335550 | Antimicrobial peptides of the genus Bacillus: a new era for antibiotics. |
| Q33869297 | Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds |
| Q39160453 | Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines |
| Q64892239 | Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii. |
| Q37450764 | Atomic force microscopy investigation of the morphology and topography of colistin-heteroresistant Acinetobacter baumannii strains as a function of growth phase and in response to colistin treatment |
| Q35169023 | Autophagy regulates colistin-induced apoptosis in PC-12 cells |
| Q28365026 | Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014 |
| Q34095133 | Baicalin inhibits colistin sulfate-induced apoptosis of PC12 cells |
| Q30235064 | Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options |
| Q38068604 | Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective |
| Q90653380 | Broadening Activity of Polymyxin by Quaternary Ammonium Grafting |
| Q34103100 | Brucella abortus choloylglycine hydrolase affects cell envelope composition and host cell internalization |
| Q89494971 | COLR Acinetobacter baumannii sRNA Signatures: Computational Comparative Identification and Biological Targets |
| Q36290642 | Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes |
| Q36571918 | Characterization of Polymyxin B Biodistribution and Disposition in an Animal Model |
| Q48643685 | Characterizing the effect of polymyxin B antibiotics to lipopolysaccharide on Escherichia coli surface using atomic force microscopy. |
| Q92972536 | CherryPicker: An Algorithm for the Automated Parametrization of Large Biomolecules for Molecular Simulation |
| Q49710326 | Claramines : A new class of broad-spectrum antimicrobial agents with bimodal activity |
| Q92302896 | Clinical Use of Polymyxin B |
| Q36158501 | Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods |
| Q60919466 | Colistin Resistant : Genomic and Transcriptomic Traits Acquired Under Colistin Therapy |
| Q40719307 | Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance |
| Q35432770 | Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance |
| Q35008357 | Colistin and polymyxin B: peas in a pod, or chalk and cheese? |
| Q34057439 | Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme |
| Q46581461 | Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity |
| Q44038984 | Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units |
| Q84941144 | Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia |
| Q33798324 | Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. |
| Q90387918 | Colistin-resistance-mediated bacterial surface modification sensitizes phage infection |
| Q38232199 | Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date |
| Q42701999 | Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii. |
| Q60917488 | Comparative Metabolomics and Transcriptomics Reveal Multiple Pathways Associated with Polymyxin Killing in Pseudomonas aeruginosa |
| Q55405783 | Comparative genomic analysis of Acinetobacter spp. plasmids originating from clinical settings and environmental habitats. |
| Q42287771 | Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii |
| Q34088577 | Contribution of bacterial outer membrane vesicles to innate bacterial defense. |
| Q49926677 | Correlations among Resistances to Different Antimicrobial Compounds in Salmonella Strains from Hen Eggshells. |
| Q51542121 | Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? |
| Q43127814 | Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection |
| Q33676198 | Detection of KPC in Acinetobacter spp. in Puerto Rico |
| Q41009249 | Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran |
| Q37669021 | Development and validation of a liquid chromatography-mass spectrometry assay for polymyxin B in bacterial growth media. |
| Q93015814 | Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections |
| Q42816882 | Differential Role of Two-Component Regulatory Systems (phoPQ and pmrAB) in Polymyxin B Susceptibility of Pseudomonas aeruginosa |
| Q91936115 | Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates |
| Q41576592 | Draft genome sequence of Paenibacillus sp. strain OSY-SE, a bacterium producing the novel broad-spectrum lipopeptide antibiotic paenibacterin |
| Q33769180 | Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival, and pathogenesis |
| Q89635867 | Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model |
| Q42119891 | Efficient production of polymyxin in the surrogate host Bacillus subtilis by introducing a foreign ectB gene and disrupting the abrB gene |
| Q42844862 | Emergence of KPC-producing Pseudomonas aeruginosa in Trinidad and Tobago |
| Q92715037 | Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review |
| Q53707227 | Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections. |
| Q44531141 | Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro |
| Q92378764 | Evaluation of the interaction between polymyxin B and Pseudomonas aeruginosa biofilm and planktonic cells: reactive oxygen species induction and zeta potential |
| Q34809662 | Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications |
| Q35041371 | Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations |
| Q37910758 | Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia |
| Q38037528 | Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. |
| Q44852902 | Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus |
| Q28552767 | From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB) |
| Q100954881 | Genome analysis reveals probiotic prop-ensities of Paenibacillus polymyxa HK4 |
| Q40983100 | Genomic characterization of Salmonella bacteriophages isolated from India |
| Q43574112 | Graft copolymer polyelectrolyte complexes for delivery of cationic antimicrobial peptides |
| Q50439892 | Guanidinium-pendant oligofluorene for rapid and specific identification of antibiotics with membrane-disrupting ability. |
| Q36281234 | Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations |
| Q37000834 | Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates |
| Q54324569 | High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden. |
| Q36089663 | High performance liquid chromatography-mass spectrometry assay for polymyxin B1 and B2 in human plasma |
| Q37826436 | How I manage haematology patients with septic shock |
| Q42132529 | Identification of a polymyxin synthetase gene cluster of Paenibacillus polymyxa and heterologous expression of the gene in Bacillus subtilis |
| Q34049989 | Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans |
| Q38543520 | Imipenem Resistant Pseudomonas aeruginosa: The fall of the final quarterback |
| Q34766191 | Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes |
| Q41827843 | In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae |
| Q37712983 | In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy |
| Q41870412 | In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates |
| Q37937558 | Inhaled antibiotics for gram-negative respiratory infections |
| Q40065788 | Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of Staphylococcus aureus towards Polymyxins |
| Q97540684 | Inhibition of the ATP synthase sensitizes Staphylococcus aureus towards human antimicrobial peptides |
| Q35076900 | Insect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans model |
| Q57797537 | Intracellular localization of polymyxins in human alveolar epithelial cells |
| Q46516945 | Intravenous colistimethate for multidrug-resistant Gram-negative bacteria |
| Q34172665 | Isolation of a Paenibacillus sp. strain and structural elucidation of its broad-spectrum lipopeptide antibiotic |
| Q38001333 | Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns |
| Q38466356 | LC–MS/MS method development and validation for the determination of polymyxins and vancomycin in rat plasma |
| Q39076004 | Lipidated cyclic γ-AApeptides display both antimicrobial and anti-inflammatory activity. |
| Q34421551 | Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates |
| Q49949238 | Lysine Analogue of Polymyxin B as a Significant Opportunity for Photodynamic Antimicrobial Chemotherapy |
| Q35168993 | Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells |
| Q47273930 | Mechanism-based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection Model. |
| Q26749527 | Mechanisms and consequences of bacterial resistance to antimicrobial peptides |
| Q35541353 | Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria |
| Q59798253 | Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant |
| Q37071179 | Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species |
| Q54347011 | Mimicking an antimicrobial peptide polymyxin B by use of cyclodextrin. |
| Q37355116 | Molecular Epidemiology of Multi-Drug Resistant Acinetobacter baumannii Isolated in Shandong, China |
| Q34565080 | Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid A. |
| Q34057293 | Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43. |
| Q37656243 | Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy |
| Q50591201 | Novel Insights into the Direct Removal of Endotoxin by Polymyxin B Hemoperfusion. |
| Q26991771 | Novel formulations for antimicrobial peptides |
| Q36870899 | Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents |
| Q57831037 | Novobiocin Enhances Polymyxin Activity by Stimulating Lipopolysaccharide Transport |
| Q37910022 | Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review |
| Q92091401 | Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli |
| Q34074686 | Outer membrane lipoprotein Lpp is Gram-negative bacterial cell surface receptor for cationic antimicrobial peptides |
| Q33726558 | Outer membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein |
| Q37685688 | Oxidative Stress Induced by Polymyxin E Is Involved in Rapid Killing of Paenibacillus polymyxa. |
| Q38086871 | Peptides as the next generation of anti-infectives. |
| Q44808038 | Pharmacokinetics of intravenous polymyxin B in critically ill patients. |
| Q42285293 | Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis |
| Q38994000 | Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? |
| Q34346283 | Pharmacology of polymyxins: new insights into an 'old' class of antibiotics |
| Q35381479 | Phenotypic and enzymatic comparative analysis of the KPC variants, KPC-2 and its recently discovered variant KPC-15. |
| Q33675769 | Phosphoglucomutase of Yersinia pestis is required for autoaggregation and polymyxin B resistance. |
| Q36158426 | Phospholipase A1 modulates the cell envelope phospholipid content of Brucella melitensis, contributing to polymyxin resistance and pathogenicity |
| Q36257537 | Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy |
| Q64091744 | Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity |
| Q36105647 | Polymyxin B Nephrotoxicity: From Organ to Cell Damage |
| Q40080273 | Polymyxin B containing polyion complex (PIC) nanoparticles: Improving the antimicrobial activity by tailoring the degree of polymerisation of the inert component |
| Q34429986 | Polymyxin B hemoperfusion: a mechanistic perspective |
| Q36076006 | Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections |
| Q38268318 | Polymyxin B infusion leading to cardiac arrest: a case report and literature review |
| Q36358747 | Polymyxin B inhibits the chaperone activity of Plasmodium falciparum Hsp70. |
| Q38613051 | Polymyxin B versus colistin: an update |
| Q40261888 | Polymyxin B-Induced Diffuse Cutaneous Hyperpigmentation |
| Q36915742 | Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens. |
| Q40051834 | Polymyxin Resistance in Gram-negative Pathogens |
| Q50873873 | Polymyxin derivatives: a patent evaluation (WO2012168820). |
| Q38922536 | Polymyxin: Alternative Mechanisms of Action and Resistance. |
| Q28595992 | Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features |
| Q37792479 | Polymyxins and their novel derivatives |
| Q37215935 | Polymyxins revisited |
| Q38850224 | Polymyxins: a new hope in combating Gram-negative superbugs? |
| Q38683033 | Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti-Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections |
| Q40248118 | Potential Toxicity of Polymyxins in Human Lung Epithelial Cells |
| Q40831544 | Precursor Amino Acids Inhibit Polymyxin E Biosynthesis in Paenibacillus polymyxa, Probably by Affecting the Expression of Polymyxin E Biosynthesis-Associated Genes |
| Q40299979 | Preparation and antimicrobial evaluation of polyion complex (PIC) nanoparticles loaded with polymyxin B. |
| Q34941542 | Prulifloxacin: clinical studies of a broad-spectrum quinolone agent |
| Q38599969 | Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies |
| Q35084559 | Pseudomonas aeruginosa: resistance to the max |
| Q34689439 | Pulmonary surfactant preserves viability of alveolar type II cells exposed to polymyxin B in vitro |
| Q41868034 | Rapid determination of colistin resistance in clinical strains of Acinetobacter baumannii by use of the micromax assay |
| Q36364121 | Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway |
| Q48204319 | Reduction in hepatic secondary bile acids caused by short-term antibiotic-induced dysbiosis decreases mouse serum glucose and triglyceride levels |
| Q40111993 | Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence. |
| Q92302832 | Reviving Polymyxins: Achievements, Lessons and the Road Ahead |
| Q84332021 | Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit |
| Q41532045 | Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study. |
| Q42116755 | Rosmarinic Acid and Its Methyl Ester as Antimicrobial Components of the Hydromethanolic Extract of Hyptis atrorubens Poit. (Lamiaceae). |
| Q84974907 | Safety in treatment of ventilator‐associated pneumonia due to extensive drug‐resistant Acinetobacter Baumannii with aerosolized colistin in neonates: A preliminary report |
| Q26799911 | Sepsis: From Pathophysiology to Individualized Patient Care |
| Q34057453 | Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance. |
| Q47781226 | Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B. |
| Q58422163 | Short Syntheticβ-Sheet Forming Peptide Amphiphiles as Broad Spectrum Antimicrobials with Antibiofilm and Endotoxin Neutralizing Capabilities |
| Q51736541 | Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules. |
| Q33354067 | Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria? |
| Q42546144 | Stable polymyxin B susceptibility to Pseudomonas aeruginosa and Acinetobacter spp. despite persistent recovery of these organisms from respiratory secretions of patients with ventilator-associated pneumonia treated with this drug |
| Q37713223 | Structure and Function of AApeptides. |
| Q34010143 | Structure--activity relationships of polymyxin antibiotics |
| Q37132339 | Structures of aminoarabinose transferase ArnT suggest a molecular basis for lipid A glycosylation |
| Q34565093 | Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae. |
| Q37912231 | Surveillance and management of multidrug-resistant microorganisms |
| Q46277815 | Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria |
| Q93115370 | Synergistic Antimicrobial Activity by Light or Thermal Treatment and Lauric Arginate: Membrane Damage and Oxidative Stress |
| Q41159517 | Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa. |
| Q48324653 | Syntheses and structure-membrane active antimicrobial activity relationship of alkylamino-modified glucose, maltooligosaccharide, and amylose |
| Q41310768 | Synthesis and Surface Activity of Cationic Amino Acid-Based Surfactants in Aqueous Solution |
| Q42208168 | Synthesis of Lipid A and Inner Core LPS ligands containing 4-amino-4-deoxy-l-arabinose units |
| Q52648087 | Synthesis of antimicrobial cyclodextrins bearing polyarylamino and polyalkylamino groups via click chemistry for bacterial membrane disruption. |
| Q89460926 | Synthetic Immunotherapeutics against Gram-negative Pathogens |
| Q45880879 | Target-Pathogen: a structural bioinformatic approach to prioritize drug targets in pathogens |
| Q34248092 | Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infections |
| Q60949800 | The Prevalence of Colistin Resistant Strains and Antibiotic Resistance Gene Profiles in Funan River, China |
| Q39196411 | The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro. |
| Q61800596 | The aqueous extract of aged black garlic ameliorates colistin-induced acute kidney injury in rats |
| Q40251304 | The development of antimicrobial a-AApeptides that suppress proinflammatory immune responses. |
| Q39358619 | The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria |
| Q28660009 | The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials |
| Q43438799 | The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic |
| Q35896916 | The licorice pentacyclic triterpenoid component 18β-glycyrrhetinic acid enhances the activity of antibiotics against strains of methicillin-resistant Staphylococcus aureus |
| Q36179001 | The polymyxin B-induced transcriptomic response of a clinical, multidrug-resistant Klebsiella pneumoniae involves multiple regulatory elements and intracellular targets |
| Q34969565 | The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria |
| Q27698393 | The structure of apo ArnA features an unexpected central binding pocket and provides an explanation for enzymatic cooperativity |
| Q31140261 | The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria. |
| Q42270991 | To study the clinical efficacy and nephrotoxicity along with the risk factors for acute kidney injury associated with parenteral polymyxin B. |
| Q37132130 | Transcriptomic Analysis of the Activity of a Novel Polymyxin against Staphylococcus aureus |
| Q52695014 | Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. |
| Q38906880 | Treatment of endotoxaemia and septicaemia in the equine patient |
| Q92633929 | Ultrashort Cationic Lipopeptides-Effect of N-Terminal Amino Acid and Fatty Acid Type on Antimicrobial Activity and Hemolysis |
| Q33798384 | Uptake of polymyxin B into renal cells |
Search more.